ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 434

$522K Total Retail Price of All Prescriptions

Rank: 37 out of 434

745 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 745 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 745 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,224 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

12% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 712 660 1 1
LOVASTATIN 451 404 2 10
SIMVASTATIN 443 409 3 2
LEVOTHYROXINE SODIUM 398 384 4 3
OMEPRAZOLE 388 340 5 5
HYDROCODONE-ACETAMINOPHEN 387 274 S3 6 4
METFORMIN HCL 386 362 7 7
ZOLPIDEM TARTRATE 313 264 8 11
AMLODIPINE BESYLATE 296 262 9 6
ALENDRONATE SODIUM 288 280 10 15
LOSARTAN POTASSIUM 246 229 11 13
ATORVASTATIN CALCIUM 233 201 12 19
ATENOLOL 217 197 13 16
FUROSEMIDE 162 152 14 9
METOPROLOL TARTRATE 162 158 14 12
FINASTERIDE 139 135 16 54
POTASSIUM CHLORIDE 137 133 17 20
GEMFIBROZIL 131 114 18 62
FLUTICASONE PROPIONATE 118 104 19 26
ADVAIR DISKUS 111 111 20 52
GLYBURIDE 106 97 R 21 51
TERAZOSIN HCL 101 98 22 40
GABAPENTIN 101 79 22 14
WARFARIN SODIUM 97 87 24 18
CARVEDILOL 93 84 25 24
FLUOXETINE HCL 91 87 26 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 69 27 21
GLIPIZIDE 83 49 28 37
HYDROCHLOROTHIAZIDE 81 64 29 8
DONEPEZIL HCL 78 78 30 35
OXYCODONE HCL-ACETAMINOPHEN 77 51 S2 31 53
TAMSULOSIN HCL 77 71 31 29
CITALOPRAM HBR 77 58 31 23
TIZANIDINE HCL 73 35 34 88
PROAIR HFA 70 69 35 60
AZITHROMYCIN 68 52 36 38
BENAZEPRIL HCL 68 64 36 49
METOPROLOL SUCCINATE 68 65 36 22
RANITIDINE HCL 68 64 36 31
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 40 39
ALLOPURINOL 57 57 41 25
PAROXETINE HCL 56 56 42 61
OXYCODONE HCL 55 28 S2 43 34
CIPROFLOXACIN HCL 55 54 43 55
CLOPIDOGREL 53 37 45 41
OXYBUTYNIN CHLORIDE 52 49 46 82
GLIMEPIRIDE 50 47 47 58
DIGOXIN 50 50 47 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.